Cargando…
Corrigendum to: Optimisation of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9 to 12 months after treatment
Autores principales: | Nordell, Fabian, Hallal, Ghadir, Asp, Pernilla, Almquist, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743050/ https://www.ncbi.nlm.nih.gov/pubmed/34999747 http://dx.doi.org/10.1093/bjsopen/zrab144 |
Ejemplares similares
-
Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9–12 months after treatment
por: Nordell, Fabian, et al.
Publicado: (2021) -
Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]
Publicado: (2017) -
NECTIN4 Promotes Papillary Thyroid Cancer Cell Proliferation, Migration, and Invasion and Triggers EMT by Activating AKT [Corrigendum]
Publicado: (2019) -
Corrigendum: Affiliation Correction. Development and Validation of a Risk Scoring System Derived from Meta-Analyses for Papillary Thyroid Cancer
por: Suh, Sunghwan, et al.
Publicado: (2023) -
Corrigendum to “Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages”
por: Zhu, Xu-Hang, et al.
Publicado: (2018)